Hao Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hao Wu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Chen-Xiao Shan
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China
1 shared publication - Chuan Chai
College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
1 shared publication - Erlin Sun
Second Hospital of Tianjin Medical University
1 shared publication - Fang Fang
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Hongmei Wen
School of Pharmacy Nanjing University of Chinese Medicine Nanjing Jiangsu China
1 shared publication Houcai Huang
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 5851315
Ming‐Mu‐Di‐Huang‐Pill Activates SQSTM1 via AMPK‐Mediated Autophagic KEAP1 Degradation and Protects RPE Cells from Oxidative Damage
Oxidative stress and diminished autophagy in the retinal pigment epithelium (RPE) play crucial roles in the pathogenesis of age‐related macular degeneration (AMD). Enhancing autophagy has recently been identified as an important strategy to protect RPE cells from oxidative damage. Ming‐Mu‐Di‐Huang‐Pill (MMDH pill) is a traditional herbal medicine used to treat AMD, and its molecular mechanism is not well understood. The aim of the present study was to investigate whether the MMDH pill relieved acute oxidative damage by activating autophagy in an in vitro and in vivo model of sodium iodate (NaIO3). The results showed that NaIO3 induced cell death and inhibited proliferation. The MMDH pill increased cell viability, restored the activities of antioxidant enzymes, and reduced reactive oxygen species (ROS) fluorescence intensity. The MMDH pill mediated Kelch‐like ECH‐associated protein 1 (Keap1) degradation and decreased oxidative damage, which was blocked in autophagy inhibitor (chloroquine) or sequestosome‐1 (SQSTM1) siRNA‐treated RPE cells. Furthermore, we indicated that the MMDH pill could promote adenosine monophosphate‐activated protein kinase (AMPK) phosphorylation and autophagy adaptor‐SQSTM1 expression, which could stimulate autophagic degradation of Keap1. In addition, the MMDH pill increased nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2) nuclear translocation in a SQSTM1‐dependent manner and induced the expression of the downstream antioxidant factors heme oxygenase‐1 (HO‐1) and nicotinamide adenine dinucleotide phosphate quinone dehydrogenase 1 (NQO1). In conclusion, MMDH pill plays a protective role in relieving NaIO3‐induced oxidative stress by activating the AMPK/SQSTM1/Keap1 pathway. The MMDH pill may be useful to treat AMD by maintaining redox homeostasis and autophagy.
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 5851315
Open AccessMing‐Mu‐Di‐Huang‐Pill Activates SQSTM1 via AMPK‐Mediated Autophagic KEAP1 Degradation and Protects RPE Cells from Oxidative Damage
Oxidative stress and diminished autophagy in the retinal pigment epithelium (RPE) play crucial roles in the pathogenesis of age‐related macular degeneration (AMD). Enhancing autophagy has recently been identified as an important strategy to protect RPE cells from oxidative damage. Ming‐Mu‐Di‐Huang‐Pill (MMDH pill) is a traditional herbal medicine used to treat AMD, and its molecular mechanism is not well understood. The aim of the present study was to investigate whether the MMDH pill relieved acute oxidative damage by activating autophagy in an in vitro and in vivo model of sodium iodate (NaIO3). The results showed that NaIO3 induced cell death and inhibited proliferation. The MMDH pill increased cell viability, restored the activities of antioxidant enzymes, and reduced reactive oxygen species (ROS) fluorescence intensity. The MMDH pill mediated Kelch‐like ECH‐associated protein 1 (Keap1) degradation and decreased oxidative damage, which was blocked in autophagy inhibitor (chloroquine) or sequestosome‐1 (SQSTM1) siRNA‐treated RPE cells. Furthermore, we indicated that the MMDH pill could promote adenosine monophosphate‐activated protein kinase (AMPK) phosphorylation and autophagy adaptor‐SQSTM1 expression, which could stimulate autophagic degradation of Keap1. In addition, the MMDH pill increased nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2) nuclear translocation in a SQSTM1‐dependent manner and induced the expression of the downstream antioxidant factors heme oxygenase‐1 (HO‐1) and nicotinamide adenine dinucleotide phosphate quinone dehydrogenase 1 (NQO1). In conclusion, MMDH pill plays a protective role in relieving NaIO3‐induced oxidative stress by activating the AMPK/SQSTM1/Keap1 pathway. The MMDH pill may be useful to treat AMD by maintaining redox homeostasis and autophagy.
- Open Access
- 9 November 2020
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 570876
Corrigendum: Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized Rats
Corrigendum: Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized Rats
- 9 November 2020
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 570876
Open AccessCorrigendum: Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized Rats
Corrigendum: Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized Rats
- 1 February 2019
- Published by Springer Nature in Acta Oceanologica Sinica
- Vol. 38 (2) , 24-33
Multi-year assessment of paralytic shellfish toxins in hard clam species along the coastline of Jiangsu Province, China
- 1 February 2019
- Published by Springer Nature in Acta Oceanologica Sinica
- Vol. 38 (2) , 24-33
Multi-year assessment of paralytic shellfish toxins in hard clam species along the coastline of Jiangsu Province, China